Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Price:
0.0625 USD
4.17%
Market Closed
Updated:
Jun 1, 2024
Aridis Pharmaceuticals Inc
Intangible Assets
|
Aridis Pharmaceuticals Inc
Intangible Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
|
Intangible Assets
$17k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Intangible Assets
$62.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
43%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Intangible Assets
$23.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Intangible Assets
$31.4B
|
CAGR 3-Years
25%
|
CAGR 5-Years
35%
|
CAGR 10-Years
9%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Intangible Assets
$834.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Intangible Assets
$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aridis Pharmaceuticals Inc's Intangible Assets?
Intangible Assets
17k
USD
17k
USD
Based on the financial report for Dec 31, 2022, Aridis Pharmaceuticals Inc's Intangible Assets amounts to 17k USD.
What is Aridis Pharmaceuticals Inc's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-16%
-16%
Over the last year, the Intangible Assets growth was -15%. The average annual Intangible Assets growth rates for Aridis Pharmaceuticals Inc have been -17% over the past three years , -16% over the past five years .
You don't have any saved screeners yet
